Answer
Capivasertib (Truqap) is not recommended during pregnancy or in women of childbearing potential not using contraception because there are no data in pregnant women and animal studies have shown reproductive toxicity.
Sources for this answer
- Truqap 160 mg film-coated tabletsAstraZeneca UK Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 6Document updated
Sources checked